189 related articles for article (PubMed ID: 15937951)
41. Analysis of Jembrana disease virus mRNA transcripts produced during acute infection demonstrates a complex transcription pattern.
Stewart ME; Desport M; Setiyaningsih S; Hartaningsih N; Wilcox GE
Virus Res; 2008 Aug; 135(2):336-9. PubMed ID: 18466992
[TBL] [Abstract][Full Text] [Related]
42. Insights on HIV-1 Tat:P/CAF bromodomain molecular recognition from in vivo experiments and molecular dynamics simulations.
Pantano S; Marcello A; Ferrari A; Gaudiosi D; Sabò A; Pellegrini V; Beltram F; Giacca M; Carloni P
Proteins; 2006 Mar; 62(4):1062-73. PubMed ID: 16362936
[TBL] [Abstract][Full Text] [Related]
43. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
[TBL] [Abstract][Full Text] [Related]
44. Splicing affects presentation of RNA dimerization signals in HIV-2 in vitro.
Lanchy JM; Szafran QN; Lodmell JS
Nucleic Acids Res; 2004; 32(15):4585-95. PubMed ID: 15333691
[TBL] [Abstract][Full Text] [Related]
45. HIV-1 Rev can specifically interact with MMTV RNA and upregulate gene expression.
Dangerfield JA; Hohenadl C; Egerbacher M; Kodajova P; Salmons B; Günzburg WH
Gene; 2005 Sep; 358():17-30. PubMed ID: 16023306
[TBL] [Abstract][Full Text] [Related]
46. The role of the tnv protein and tnv RNA splicing signals in replication of HIV-1 IIIB isolates.
Göttlinger HG; Dorfman T; Cohen EA; Haseltine WA
Virology; 1992 Aug; 189(2):618-28. PubMed ID: 1641982
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
[TBL] [Abstract][Full Text] [Related]
48. Quantitative study of the control of HIV-1 gene expression.
Hammond BJ
J Theor Biol; 1993 Jul; 163(2):199-221. PubMed ID: 8246504
[TBL] [Abstract][Full Text] [Related]
49. HIV-1: To Splice or Not to Splice, That Is the Question.
Emery A; Swanstrom R
Viruses; 2021 Jan; 13(2):. PubMed ID: 33530363
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of HIV-1 multiplication by a modified U7 snRNA inducing Tat and Rev exon skipping.
Asparuhova MB; Marti G; Liu S; Serhan F; Trono D; Schümperli D
J Gene Med; 2007 May; 9(5):323-34. PubMed ID: 17474072
[TBL] [Abstract][Full Text] [Related]
51. An anti-apoptotic protein, Hax-1, inhibits the HIV-1 rev function by altering its sub-cellular localization.
Modem S; Reddy TR
J Cell Physiol; 2008 Jan; 214(1):14-9. PubMed ID: 17929250
[TBL] [Abstract][Full Text] [Related]
52. Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA.
Nasioulas G; Zolotukhin AS; Tabernero C; Solomin L; Cunningham CP; Pavlakis GN; Felber BK
J Virol; 1994 May; 68(5):2986-93. PubMed ID: 8151769
[TBL] [Abstract][Full Text] [Related]
53. RNA structure modulates splicing efficiency at the human immunodeficiency virus type 1 major splice donor.
Abbink TE; Berkhout B
J Virol; 2008 Mar; 82(6):3090-8. PubMed ID: 18160437
[TBL] [Abstract][Full Text] [Related]
54. Promoter proximal splice sites enhance transcription.
Furger A; O'Sullivan JM; Binnie A; Lee BA; Proudfoot NJ
Genes Dev; 2002 Nov; 16(21):2792-9. PubMed ID: 12414732
[TBL] [Abstract][Full Text] [Related]
55. Strategies to quantify unspliced and multiply spliced mRNA expression in HIV-2 infection.
Soares RS; Matoso P; Calado M; Sousa AE
J Virol Methods; 2011 Jul; 175(1):38-45. PubMed ID: 21540056
[TBL] [Abstract][Full Text] [Related]
56. HIV-1 Tat commandeers nuclear export of Rev-viral RNA complex by controlling hnRNPA2-mediated splicing.
Yandrapally S; Sarkar S; Banerjee S
J Virol; 2023 Nov; 97(11):e0104423. PubMed ID: 37905837
[TBL] [Abstract][Full Text] [Related]
57. Activation of a cryptic splice donor in human immunodeficiency virus type-1.
Borg KT; Favaro JP; Arrigo SJ; Schmidt M
J Biomed Sci; 1999 Jan; 6(1):45-52. PubMed ID: 9933742
[TBL] [Abstract][Full Text] [Related]
58. Sequence analysis of mRNA transcripts encoding Jembrana disease virus Tat-1 in vivo.
Setiyaningsih S; Desport M; Stewart ME; Hartaningsih N; Wilcox GE
Virus Res; 2008 Mar; 132(1-2):220-5. PubMed ID: 18096262
[TBL] [Abstract][Full Text] [Related]
59. The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly.
Si ZH; Rauch D; Stoltzfus CM
Mol Cell Biol; 1998 Sep; 18(9):5404-13. PubMed ID: 9710624
[TBL] [Abstract][Full Text] [Related]
60. Novel mono- and di-DNA-enzymes targeted to cleave TAT or TAT-REV RNA inhibit HIV-1 gene expression.
Unwalla H; Banerjea AC
Antiviral Res; 2001 Aug; 51(2):127-39. PubMed ID: 11431037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
